@adomuminovic@thesamparr@SamiRafi1 Or if the industry expected rate is 1 lawsuit per 5 years, then they adjust to include 20% of the expense for the year
$CNXU โ REGENERATIVE MEDICINE PLATFORM + TISSUE REGENERATION ๐
Conexeu Sciences is changing the game in surgery. Instead of permanent implants, theyโve developed a collagen scaffold that helps the body regenerate its own living tissue. Itโs a scalable, IP-protected platform built for wound care and reconstruction.
Whatโs standing out:
๐น One platform with applications ranging from wound care to 3D-printed breast reconstruction.
๐น Partnership with Wake Forest (WFIRM) on the B.R.E.A.S.T.โข program.
๐น Global patent portfolio with no royalty burdens.
๐น Targeting 510(k) approval by early 2027.
Communicated Disclaimer - https://t.co/jbTAx2OLXO
$REPL $GOVX $QURE $CUE
@itsmichaelluu@SuperLuckeee There's only 550 million shares of SpaceX initially. Say 100 institutions buy 3 million shares each. That doesn't even put a dent in NVDA 23 BILLION share float.